Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer

Molecular Carcinogenesis

Volumn 55, Issue 5, 2016, Pages 537-551

  Islam, S S ^a   Mokhtari, R B ^a   Noman, A S ^b   Uddin, M ^a   Rahman, M Z ^c   Azadi, M A ^b   Zlotta, A ^d   van der Kwast, T ^e   Yeger, H ^a   Farhat, W A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF CHITTAGONG   (Bangladesh)

^c CHITTAGONG MEDICAL COLLEGE   (Bangladesh)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bladder cancer; EMT; Shh

Indexed keywords

CYCLOPAMINE; HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; PROTEIN ZO1; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VISMODEGIB; SHH PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CLONOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WOUND HEALING; ANIMAL; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CANCER TRANSPLANTATION; CELL MOTION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; MICE; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; URINARY BLADDER NEOPLASMS;

EID: 84923673528     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22300     Document Type: Article

References (37)

1. Murta-Nascimento C, Schmitz-Drager BI, Zeegers MP, et al. Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 2007; 25: 285-295.
2. Siegal R, Naishadham D, Jemal A. Cancer Statistics. CA Cancer J Clin 2012; 62: 10- 19.
3. Ploeg M, Aben KK, Kienreney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293.
4. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int 2002; 89: 868-878.
5. Lorusso V, Silvestris N. Systematic chemotherapy for patients with advanced and metastatic bladder cancer: Current status and future directions. Ann Oncol 2005; 16: iv85-iv89.
6. Williams PD, Stein JP. Molecular pathways in bladder cancer. Urol Res 2004; 32: 373-385.
7. McConkey DJ, Choi W, Marquis L, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009; 28: 335-344.
8. Gavart N, Ben-Ze've A. Epithelial-mesenchymal transition and invasive potential of tumors. Trends Mol Med 2008; 14: 199-209.
9. Nawshad A, Lagamba D, Poland A, Hay ED. Transforming growth factor-β signaling during epithelia-mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005; 179: 11-23.
10. Mani SA, Guo W, Lino MS, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704- 715.
11. McConkey DJ, Lee S, Choi W, et al. Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol Oncol 2010; 28: 429- 440.
12. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645- 659.
13. Berman DM, Karhadkav SS, Maitra A. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425: 846-851.
14. He H, Chen J, Chen X, et al. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res 2012; 18: 349-355.
15. Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH. Upregulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011; 6: e16068.
16. Katoh Y, Katoh M. Hedgehog signaling, epithelial-mesenchymal transition and mRNA (Review). Int J Mol Med 2008; 22: 271-273.
17. Theunission JW, de Sauvage FJ. Paracrine hedgehog signaling in cancer. Cancer Res 2009; 69: 6007-6010.
18. Walter K, Omura N, Hong SM. Overexpression of Smoothened activates the sonic hedgehog-signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res 2009; 16: 1781-1789.
19. Alvarez J, Sohn P, Zeng X, Doetschman T, Robbins DJ, Serra R. TGF- beta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. Development 2002; 129: 1913-1924.
20. Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expressions in osteoblasts in response to hedgehog signaling. Mol Cell Biol 2006; 26: 6197-6208.
21. Fan Q, He M, Sheng T, et al. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. J Biol Chem 2010; 285: 36570-36576.
22. Yoo YA, Kang MH, Kim JS, OH SC. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta- mediated activation of the ALK5-Smad3 pathway. Carcinogenesis 2008; 29: 480-490.
23. Islam SS, Mokhtari RB, El-Hout Y, et al. TGF-beta1 induces EMT reprograming of porcine bladder urothelial cells into collagen producing fibroblast-like cells in a Smad2/Smad3 dependent manner. J Cell Commun Signal 2013; Doi: 10.1007/s12079-013-0216-4
24. Lan L, Luo Y, Cui D, et al. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 2013; 43: 113-120.
25. Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of Gli2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res 2007; 67: 10642-10646.
26. Pignot G, Vicillefond A, Vacher S, et al. Hedgehog pathway activation in human transitional cell carcinoma of the bladder. Br J Cancer 2012; 106: 1177-1186.
27. Liu MS, Yang PY, Yeh TS. Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas 2007; 34: 340-346.
28. Feldmann G, Dhara S, Fendrich V, et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastasis: A new paradigm for combination therapy in solid cancers. Cancer Res 2007; 67: 2187-2196.
29. Varjosalo M, Taipale J. Hedgehog: Functions and mechanisms. Genes Dev 2008; 22: 2454-2472.
30. Shin K, Lee J, Kim J, et al. Hedgehog/Wnt feed back supports regenerative proliferation of epithelial stem cells in bladder. Nature 2011; 472: 110- 114.
31. Clement V, Sanchez P, de Tribolet N, et al. Hedgehog-Gli signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165-172.
32. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23: 675- 699.
33. Baba T, Convery PA, Matsumara N, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133 + ovarian cancer cells. Oncogene 2009; 28: 209- 218.
34. Chan KS, Espinosa I, Chao M, et al. Identification molecular characterization clinical prognosis therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 2009; 106: 14016-14021.
35. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. Oct4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007; 120: 1598-1602.
36. Chann K, Espinosa I, Chao M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder can-initiating cells. Proc Natl Acad Sci USA 2009; 106: 14016-14021.
37. Shin K, Lim A, Zhao C, et al. Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell 2014; 26: 521-533.